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Abstract
Introduction: Exposure to maternal smoking early in life may affect blood pressure (BP) control 
mechanisms. We examined the association between maternal smoking (before conception, during 
pregnancy, and 4 years after delivery) and BP in preschool children.
Methods: We evaluated 4295 of Generation XXI children, recruited at birth in 2005–2006 and reeval-
uated at the age of 4. At birth, information was collected by face-to-face interview and additionally 
abstracted from clinical records. At 4-year follow-up, interviews were performed and children’s 
BP measured. Linear regression models were fitted to estimate the association between maternal 
smoking and children’s BP.
Results: Children of smoking mothers presented significantly higher BP levels. After adjustment 
for maternal education, gestational hypertensive disorders, and child’s body mass index, children 
exposed during pregnancy to maternal smoking presented a higher systolic BP (SBP) z-score 
(β = 0.08, 95% confidence interval [CI] 0.04 to 0.14). In crude models, maternal smoking was associ-
ated with higher SBP z-score at every assessed period. However, after adjustment, an attenuation 
of the association estimates occurred (β = 0.08, 95% CI 0.03 to 0.13 before conception; β = 0.07, 
95%CI 0.02 to 0.12; β = 0.04, 95%CI −0.02 to 0.10; and β = 0.06, 95%CI 0.00 to 0.13 for the first, 
second, and third pregnancy trimesters, respectively; and β = 0.07, 95%CI 0.02 to 0.12 for current 
maternal smoking). No significant association was observed for diastolic BP z-score levels.
Conclusion: Maternal smoking before, during, and after pregnancy was independently associated 
with systolic BP z-score in preschool children. This study provides additional evidence to the public 
health relevance of maternal smoking cessation programs if early cardiovascular health of children 
is envisaged.
Implications: Using observational longitudinal data from the birth cohort Generation XXI, this 
study showed that exposure to maternal smoking—before pregnancy, during pregnancy, and 
4 years after delivery—was associated with a systolic BP-raising effect in children at the age of 
4. The findings of this study add an important insight into the need to support maternal smoke-free 
environments in order to provide long-term cardiovascular benefit, starting as early as possible in 
life.
Downloaded from https://academic.oup.com/ntr/advance-article-abstract/doi/10.1093/ntr/ntx117/3859608
by Universidade do Porto user
on 04 April 2018
Nicotine & Tobacco Research, 2017, Vol. 00, No. 002
Introduction
Smoking is worldwide the most common preventable cause of mor-
bidity and mortality.1,2 Every year, it is responsible for nearly 6 million 
deaths, of which more than 5 million result directly from smoking and 
over 600 000 occur in nonsmokers due to passive exposure.3 Despite 
a global decrease in prevalence,4 one billion adults are smokers.5 Most 
are aged 20– 40 years, the child-bearing age, and when more time 
is expected to be spent by parents with children.4 This contributes 
to expose approximately 700 million children worldwide to second-
hand smoke (SHS), mostly at home.6,7 However, smoking influences 
the life course since intrauterine life. Research into maternal smoking 
during pregnancy suggests that alterations in fetal programming, in 
response to an adverse fetal environment, might be involved in the ori-
gins of chronic conditions later in life,8 apart from increasing the risk 
of preterm birth, intrauterine growth restriction, and perinatal death. 
Later, during the pediatric period, it increases the risk of respiratory 
illnesses, neurobehavioral problems, and poor school performance.9
It has been hypothesized that SHS exposure contributes to ather-
osclerosis, as it promotes a permanent status of inflammation, leads 
to lipid accumulation in heart blood vessels and aorta,10 and causes 
permanent vascular damage, and this process might begin in the fetal 
life.11 Maternal smoking during pregnancy and SHS exposure during 
childhood may lead to long-lasting “programming” of blood pres-
sure (BP) control mechanisms, increasing susceptibility to adverse 
outcomes, such as hypertension.12
Hypertension is the leading risk factor for severe cardiovascular 
outcomes.13 In Portugal, where the leading cause of death is stroke, 
the risk of hypertension remains higher than in other developed 
countries,14 and hypertension remains highly prevalent although 
increasing awareness and treatment resulted in decreased blood 
pressure levels.15
Growing evidence suggests that blood pressure tracks from child-
hood into adulthood,16 reflecting a complex interaction of genetic, 
behavioral, environmental, and social determinants.17,18 Evidence 
also suggests that primary hypertension is early detectable and 
occurs commonly in the young.19 Additionally, the long-term health 
risks for children with hypertension can be substantial, which makes 
it essential to adopt measures to reduce these risks and optimize 
health outcomes. Still, it is unknown when BP becomes a valid pre-
dictor of long-term cardiovascular risk.
Instead of focusing on adult life, when disease is established, 
the possibility of assessing environmental exposures longitudinally 
from before conception through pregnancy and childhood provides a 
valuable asset to better understand diseases that have fetal or devel-
opmental origins.20 Since there is a lack of report on the offspring’s 
BP measured as early as at age 4, and there are inconsistent results 
relating children’s exposure to maternal smoking and children blood 
pressure,13,21–26 the present study quantified that association at specific 
periods—before pregnancy, during pregnancy, and 4 years after deliv-
ery using data from the Portuguese birth cohort, Generation XXI.
Methods
Subjects
Generation XXI assembled a cohort of 8647 children born between 
April 2005 and August 2006 at all five public maternity units that 
served the six municipalities of the metropolitan area of Porto, 
Portugal.27 Of the invited mothers, 91.4% accepted to participate. 
Trained interviewers using structured questionnaires collected 
data on demographic and socioeconomic characteristics, lifestyles, 
obstetric history, and anthropometrics, within 72 hours of delivery, 
during the hospital stay, by face-to-face interview. Clinical records 
were also reviewed at birth.
Four years after delivery, from April 2009 until April 2011, all chil-
dren and their mothers were invited to a follow-up evaluation. Of the 
8647 children evaluated at birth, 7459 were reevaluated (86% partici-
pation proportion). For families that were not able to participate in a 
face-to-face evaluation, a telephone interview was offered (n = 1472), 
but BP was not recorded. For the purpose of the analysis, we addition-
ally excluded multiple births (n = 215); children who did not perform 
BP measurements as part of their physical assessment (n  =  1257); 
who did not live with their biological mothers (n = 87); with miss-
ing information on preconception (n = 65), pregnancy (n = 17), and 
current (n = 3) maternal smoking; mothers who reported to be smok-
ers before and during pregnancy and never smokers when questioned 
at follow-up (n = 14), missing information on mothers’ educational 
level (n = 32), and children’s anthropometric measurements (n = 2). 
Thus, the present analysis was based on the information of 4295 chil-
dren. Participants were compared to those not included, and no dif-
ferences were observed regarding mode of delivery, children’s sex, or 
body mass index (BMI) and maternal smoking at follow-up. However, 
mothers of included children had a higher number of schooling years, 
10.8 (4.2) vs. 10.0 (4.2), p < .001, and a lower proportion of tobacco 
smoking before (23.5% vs. 29.3%, p < .001) and during pregnancy 
(21.1% vs. 25.7%, p < .001).
Assessment of Exposure and Covariates
Maternal socioeconomic characteristics, personal and family his-
tory of disease, obstetric history, and behavioral factors were 
self-reported. Maternal education corresponded to the number of 
completed schooling years at delivery. Parity was recorded as the 
number of deliveries, including the index one. Prepregnancy weight 
was self-reported after delivery and recorded to the nearest 0.1 kg. 
Height was measured in centimeters, to the nearest tenth, using a 
portable stadiometer.
Hypertensive disorders in pregnancy included the presence of 
chronic hypertension, gestational hypertension, or preeclampsia/
eclampsia. Personal history of hypertension was considered pre-
sent when participants recalled a medical diagnosis of this condi-
tion before the current pregnancy, while gestational hypertension 
or preeclampsia/eclampsia were considered only when explicitly 
recorded on obstetrical records as a diagnosis during the current 
pregnancy. When gestational hypertension and preeclampsia/eclamp-
sia were simultaneously recorded in the medical record, the diagno-
sis of preeclampsia/eclampsia was considered. Smoking before and 
during pregnancy was recorded at delivery and considered if moth-
ers had ever smoked within the 3  months previous to pregnancy 
and during each trimester of pregnancy. At 4-year follow-up, mater-
nal smoking was considered if current smokers. We then grouped 
maternal smoking into three mutually exclusive categories: (1) never 
smoked (responded “no” for all three periods), (2) smoked before 
and/or after pregnancy but not during pregnancy, and (3) smoked 
during pregnancy (responded “yes” to the question on smoking dur-
ing pregnancy independent of having also responded “yes” to the 
question on smoking before and/or after pregnancy).
Blood Pressure and Other Clinical Measurements
Data on pregnancy and delivery characteristics, birthweight, and 
length were abstracted from medical records. Gestational age was 
considered as registered in medical files based on the biometric 
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measurement of the ultrasound or, if not available, on the date of 
the last menstrual period. At 4 years of age, measurements were per-
formed by trained examiners. Weight was measured in light clothing 
to the nearest 0.1 kg using a digital scale, and height was measured 
to the nearest centimeter with a wall stadiometer. BMI was calcu-
lated as weight in kg divided by height in squared meters. BMI, age-, 
and sex-specific standard deviation scores (BMI z-scores) were com-
puted according to the World Health Organization.28
BP was evaluated with an aneroid sphygmomanometer (Erka® 
Vario DeskModel) with an adequately sized cuff, by a trained exam-
iner, twice with a 5-min interval between measurements, with the 
subject in a seated position and the antecubital fossa supported at 
heart level, after at least a 5-min rest. When the difference between 
the two determinations was larger than 5 mm Hg for systolic BP 
(SBP) or diastolic BP (DBP), a third measurement was taken, and 
the mean of the 2 closest values was considered. No significant dif-
ferences were found between the average BP of the group with two 
measurements and the average of the second and third measure-
ment in the group with three measurements (SBP: 106.8 vs. 106.7, 
p = .934; DBP: 73.5 vs. 74.0, p = .617, respectively). BP SD score 
values were calculated, following the recommendations of the 
American Academy of Pediatrics, and children were classified as hav-
ing high BP levels if SBP or DBP were above the 90th percentile for 
age, gender, and height.19
Statistical Analysis
Continuous variables were presented as mean (SD), and Student t 
test was used for 2-group comparisons. Proportions were compared 
using chi-square tests. The association between maternal smoking 
and children’s BP was evaluated fitting linear regression models 
(crude and adjusted β regression coefficients (β) and 95 % confi-
dence intervals [95% CI]). Univariable models were fitted for mater-
nal smoking course and each for specific period—3 months before 
pregnancy; during first, second, and third pregnancy trimesters, and 
current smoking. Based on previous literature, we tested potential 
confounders and verified that maternal educational level, gestational 
hypertensive disorders, and child’s BMI were associated with both 
exposure and outcome. Therefore, each of maternal smoking periods 
was further adjusted for these confounders.
Statistical analyses were performed using the Statistical Package 
for the Social Sciences (IBM® SPSS® Statistics), version 23.0. 
Statistical significance was considered with an α critical value of 
0.05.
Ethics
The study was approved by the Portuguese Data Protection Agency, 
and ethical approval was obtained from the University of Porto 
Medical School and Centro Hospitalar São João ethics committee 
and the local ethics committees of the hospitals involved. A signed 
informed consent was obtained from all parents or the legal repre-
sentative of participating children.
Results
Table 1 displays maternal and child characteristics according to chil-
dren BP status. Children with higher BMI more frequently presented 
a high BP level. Patients with high BP (20%) were significantly more 
frequent among mothers who had lower educational levels, higher 
prepregnancy BMI, or who smoked before conception and during 
pregnancy (during the first and third trimester).
Table 2 presents the association between maternal smoking and 
SBP and DBP z-scores. Smoking during pregnancy was associated 
with higher children’s SBP z-score at 4 years compared to children 
of never smoking mothers, even after adjustment for potential con-
founders (β = 0.08, 95% CI 0.03 to 0.14). Maternal smoking was 
associated with higher SBP z-score levels at every period in the crude 
models; however, after adjustment, an attenuation of the association 
estimates occurred (β = 0.08, 95% CI 0.03 to 0.13 before concep-
tion; β = 0.07, 95% CI 0.02 to 0.12; β = 0.04, 95% CI −0.02 to 
0.10, and β = 0.06, 95% CI 0.00 to 0.13 for the first, second, and 
third pregnancy trimesters, respectively; and β = 0.07, 95% CI 0.02 
to 0.12 for current maternal smoking). No such association was 
observed for DBP z-score levels.
Discussion
This study showed that maternal smoking was independently associ-
ated with children’s BP at 4 years of age. We studied three different 
maternal smoking exposure periods: during preconception, consid-
ering the 3 months before pregnancy; during pregnancy, considering 
the first, second, and third trimesters; and at the time of follow-up 
evaluation. In all three periods, maternal smoking was positively 
associated with SBP z-score. This finding is in accordance with Oken 
and colleagues who also reported that children of mothers smok-
ing in pregnancy and even before pregnancy presented higher SBP 
levels at age 3.21 Similarly, Blake et al. reported higher SBP in chil-
dren exposed to prenatal smoking29 as well as Simonetti et al. who 
observed the same effect when considering parental passive smoking 
and offspring SBP z-score at age 6.13
The adverse consequences of active and passive smoking on car-
diovascular health have been well demonstrated in adults.30 The risk 
of ischemic heart disease is 2.6 times (95% CI 2.4 to 2.7) higher 
for men and 3.0 times (95% CI 2.8 to 3.2) for smoking women.31 
However, SHS exposure has emerged as a significant risk factor for 
CVD among nonsmokers, with a dose-dependent relationship.32–34 
Evidence has shown that the risk of coronary heart disease among 
SHS-exposed nonsmoking adults is 1.25 times (95% CI 1.17 to 
1.32) higher than unexposed adults.35
In children, SHS exposure has been associated with respiratory 
illnesses and infections resulting in extra visits to the emergency 
department and medical expenditures.36 Altered endothelial function 
and arterial morphology was also shown to be associated with SHS, 
indicating that childhood SHS exposure doubles the risk of carotid 
plaque in early adulthood.4,37,38 However, to our knowledge, only 
four studies addressed the role of maternal smoking on BP as early 
as at preschool age.13,21,22,39
In our study, the observed associations could reflect sociodemo-
graphic or genetic confounding rather than a causal relationship, 
and it was why we adjusted for potential confounders, namely, 
maternal education and gestational hypertensive disorders,13 but the 
adjustment did not change the results. However, the strength of the 
associations was attenuated when we further considered child’s BMI, 
a suspected effect mediator, indicating that the association between 
maternal smoking and child’s BP is partly explained by BMI. It was 
previously described an association between maternal smoking and 
a higher child’s BMI, which in turn can lead to a higher BP.21 We 
expect that a similar mechanism operates in our population.
Over the last decades, a new paradigm emerged to understand 
health risks such as obesity and cardiovascular disease, owed to the 
finding that environmental factors early in life and even in utero 
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Table 1. Mother and child characteristics according to children blood pressure statusa
Mothers’ characteristics
Blood pressure centile
<90th ≥90th
pN = 3435 (80) N = 860 (20)
Age at child’s birth, years 29.57 (5.39) 29.36 (5.57) .314
Educational level, years, %
 0–6 721 (76.9) 216 (23.1) <.001
 7–9 753 (76.3) 234 (23.7)
 10–12 995 (81.6) 225 (18.4)
 >12 966 (83.9) 185 (16.1)
Prepregnancy BMI, kg/m2 23.77 (4.20) 24.84 (4.63) <.001
Prepregnancy history of hypertension, %
 No 3247 (80.0) 813 (20.2) .830
 Yes 64 (79.0) 17 (21.0)
Gestational hypertensive disorders,%
 No 3257 (80.1) 811 (19.9) .546
 Yes 178 (78.4) 49 (21.6)
Parity
 1 2017 (80.8) 479 (19.2) .108
 >1 1418 (78.8) 381 (21.2)
Maternal smoking course
 Never smoked 2449 (80.7) 586 (19.3) .102
 Smoked before and/or after pregnancy  
(but not during pregnancy)
285 (80.3) 70 (19.7)
 Smoked during pregnancy 701 (77.5) 204 (22.5)
Smoked 3 months before pregnancy, %
 No 2651 (80.7) 633 (19.3) .027
 Yes 784 (77.5) 227 (22.5)
Smoked during pregnancy, %
First trimester
 No 2743 (80.6) 659 (19.4) .037
 Yes 692 (77.5) 201 (22.5)
Second trimester
 No 2979 (80.3) 731 (19.7) .187
 Yes 456 (77.9) 129 (22.1)
Third trimester
 No 3014 (80.4) 733 (19.6) .048
 Yes 421 (76.8) 127 (23.2)
Currently smoking, %
 No 2594 (80.5) 627 (19.5) .114
 Yes 841 (78.3) 233 (21.7)
Children’s characteristics at birth
 Gender, %
  Female 1691 (79.8) 427 (20.2) .825
  Male 1744 (80.1) 433 (19.9)
Birth weight, g 3181.04 (490.86) 3199.08 (484.63) .334
 Birth length, cm 48.74 (2.33) 48.74 (2.17) .976
 Gestational age, wk 38.63 (1.71) 38.66 (1.66) .582
Preterm (<37 gestational weeks), %
 No 3172 (79.2) 802 (20.2) .281
 Yes 261 (82.3) 56 (17.7)
Low birth weight (<2500 g), %
 No 3175 (79.8) 806 (20.2) .194
 Yes 260 (82.8) 54 (17.2)
Children’s characteristics at 4 years old
 Height, cm 105.82 (4.90) 106.96 (5.36) <.001
 BMI z-score  0.49 (1.01) 1.20 (1.29) <.001
 Systolic BP z-score 0.21 (0.60) 1.27 (0.71) <.001
 Diastolic BP z-score 0.27 (0.57) 1.16 (0.77) <.001
Abbreviation: BMI, body mass index; BP, blood pressure.
Statistical significance in bold is considered at p < .05.
aValues are expressed as mean (SD) or percentages. For each variable, the total may not add to 4295 due to missing data.
Downloaded from https://academic.oup.com/ntr/advance-article-abstract/doi/10.1093/ntr/ntx117/3859608
by Universidade do Porto user
on 04 April 2018
Nicotine & Tobacco Research, 2017, Vol. 00, No. 00 5
can profoundly influence lifelong health.40,41 We previously reported 
that the prevalence of unfavorable lifestyles and adiposity was high 
among these mothers, with the occurrence of risk factors highlight-
ing their unfavorable cardiovascular risk profile, which could poten-
tially have implications not only for themselves but also for their 
children.42,43 Maternal smoking during pregnancy is one such early 
life exposure that may have a persistent influence on offspring body 
size and cardiovascular health.21 It is believed that nicotine has a 
direct effect on the development of the fetal renal, cardiovascular, 
and nervous systems and an indirect effect through the change in 
maternal vasculature, affecting placental formation and blood 
flow.44 We tested how the different life periods of maternal smoking 
were associated with children’s BP levels and found that exposure to 
smoking during pregnancy resulted in significantly higher BP levels 
at the age of 4. We observed that 60% of mothers who reported 
ever smoking did it in all three periods—before, during pregnancy, 
and 4 years after—indicating that smoking chronicity might explain 
the observed results. However, we cannot exclude the possibility of 
smoking before and/or after pregnancy might also have some effect 
which could not be documented, given the small number of mothers 
who reported to smoke only in those periods. Also, although no sig-
nificant differences were observed, when considering current smok-
ing exposure and dividing mothers into three categories—no, never; 
no, but before or during pregnancy; and yes—a higher proportion 
of offspring with high BP levels was observed for mothers who quit 
smoking, but who had smoked before or during pregnancy (22.0%) 
and for those who were currently smoking (21.7%), compared to 
never smoking mothers (19.3%).
Recent evidence from the Avon Longitudinal Study of Parents 
and Children has shown that prenatal maternal smoking results in 
epigenetic changes in the offspring, with persistence of DNA meth-
ylation changes into adolescence.38 Although research in this area is 
in an early stage, the long-term impact of parental smoking on the 
offspring epigenome may underlie part of the atherogenic process.44 
Further animal and human studies may help elucidate pathways by 
which smoking or nicotine exposure before pregnancy might pro-
gram later BP.
Despite the remarkable progresses in smoking policies,45 house-
hold SHS exposure very much remains a contemporary issue, with 
the results of the 1999–2008 Global Youth Tobacco surveys of more 
than 350 000 children revealing that 30.4% were exposed to SHS 
inside their homes.44 SHS exposure in children is a human rights 
issue, namely, because they are unable to choose their own environ-
ments and leave smoke-exposed settings. This indicates that involun-
tary smoking will be a persistent and significant cause of morbidity 
and mortality in the years ahead.34
Policies banning smoking in work and public places have been 
widely implemented and resulted in CVD reduction.46 In 2009, the 
American Academy of Pediatrics called for children to have universal 
smoke-free home, car, school, and play environments, both inside and 
outside.47 Progress continues to be made as bans on smoking in cars 
with children have been enacted in several countries worldwide.48
Table 2. Effect of maternal smoking on offspring blood pressure levels at 4 years-old—univariable and multivariable analysis
SBP z-score DBP z-score
β 95%CI β 95%CI
Maternal smoking course
 Crude
 Never smoked Ref – Ref –
 Smoked before and/or after pregnancy (but not during 
pregnancy)
0.06 −0.02 to 0.14 −0.04 −0.12 to 0.03
 Smoked during pregnancy 0.13 0.08 to 0.18 0.00 −0.05 to 0.05
 Adjusteda
 Never smoked Ref – Ref –
 Smoked before and/or after pregnancy (but not during 
pregnancy)
0.04 −0.04 to 0.12 −0.04 −0.12 to 0.03
 Smoked during pregnancy 0.08 0.03 to 0.14 0.00 −0.05 to 0.05
Maternal smoking 3 months before pregnancyb
 Crude 0.12 0.07 to 0.18 0.04 −0.01 to 0.09
 Adjusteda 0.08 0.03 to 0.13 0.02 −0.03 to 0.07
Maternal smoking during first pregnancy trimesterb
 Crude 0.12 0.06 to 0.17 0.03 −0.03 to 0.08
 Adjusteda 0.07 0.02 to 0.12 0.00 −0.05 to 0.06
Maternal smoking during second pregnancy trimesterb
 Crude 0.10 0.03 to 0.16 0.02 −0.05 to 0.08
 Adjusteda 0.04 -0.02 to 0.10 −0.01 −0.07 to 0.05
Maternal smoking during third pregnancy trimesterb
 Crude 0.12 0.06 to 0.18 0.02 −0.04 to 0.09
 Adjusteda 0.06 0.00 to 0.13 −0.01 −0.07 to 0.06
Current maternal smokingb
 Crude 0.11 0.06 to 0.17 −0.00 −0.05 to 0.05
 Adjusteda 0.07 0.02 to 0.12 −0.03 −0.08 to 0.02
Abbreviations: β, parameter estimate; SBP, systolic blood pressure; DBP, diastolic blood pressure; BMI, body mass index; CI, confidence interval.
Statistical significance in bold is considered at p < .05.
aAdjusted for maternal educational level, gestational hypertensive disorders and child’s BMI.
bReference category are nonsmoking mothers at each period.
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The acknowledgment that childhood BP tracks into adult life,16 
although the relative contributions of genetic and environmental fac-
tors and the effect of reversibility of the latter on long-term BP tracking 
and adult cardiovascular health are not entirely clarified, reinforces the 
increasing assurance that avoiding or removing potentially irreversible 
adverse factors as early as possible are a suitable approach to follow.13
Strengths and Limitations
Since this study is based on a population-based birth cohort, there 
were losses to follow-up as expected. However, few differences were 
found between participants included and nonincluded in the present 
study, which should not have had impact on our results. The assess-
ment of smoking by questionnaire without a biochemical validation 
and social desirability, leading to underreport of smoking, might be 
limitations of our study. However, it was shown that self-reporting 
is a reliable approach to exposure ascertainment,49,50 and we believe 
that any underreporting is nondifferential. The population-based life 
course approach, the BP measurement in preschool age, the evalua-
tion of a comprehensive large group of potential confounders, and 
the novelty of assessing three different time periods in a prospective 
cohort design are strengths of the study.
Conclusion
Using data from a birth cohort with detailed information on mater-
nal smoking as well as BP measurement as early as 4 years of age, 
we found that maternal smoking before, during, and after pregnancy 
was independently associated with SBP z-score levels in preschool 
children. This study provides further reason to support innovative 
programs to reduce smoking in reproductive-age women.
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